Comparison between Religare Enterprises IPO and Saamya Biotech IPO.
Religare Enterprises IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Saamya Biotech IPO is a Mainboard Fixed Price proposed to list at BSE.
The total issue size of Religare Enterprises IPO is up to ₹140.16 Cr whereas the issue size of the Saamya Biotech IPO is up to ₹15.01 Cr. The final issue price of Religare Enterprises IPO is ₹185.00 per share and of Saamya Biotech IPO is ₹10.00 per share.
| Religare Enterprises IPO | Saamya Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹160.00 per share | |
| Issue Price (Upper) | ₹185.00 per share | |
| Issue Price (Final) | ₹185.00 per share | ₹10.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 35 shares | 500 shares |
| Fresh Issue Size | 75,76,102 shares | 1,50,12,500 shares |
| Fresh Issue Size (Amount) | up to ₹140.16 Cr | up to ₹15.01 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 75,76,102 shares | 1,50,12,500 shares |
| Issue Size Total (Amount) | up to ₹140.16 Cr | up to ₹15.01 Cr |
Religare Enterprises IPO opens on Oct 29, 2007, while Saamya Biotech IPO opens on Sep 25, 2007. The closing date of Religare Enterprises IPO and Saamya Biotech IPO is Nov 01, 2007, and Sep 28, 2007, respectively.
| Religare Enterprises IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 29, 2007 | Sep 25, 2007 |
| Issue Close | Nov 01, 2007 | Sep 28, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Nov 21, 2007 | Oct 19, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Religare Enterprises IPO P/E ratio is , as compared to Saamya Biotech IPO P/E ratio of .
| Religare Enterprises IPO | Saamya Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 60.41 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 54.36 | 35.01 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1401.58 Cr. | ₹23.08 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 7.81 |
In the Religare Enterprises IPO Retail Individual Investors (RII) are offered 22,72,831 shares while in Saamya Biotech IPO retail investors are offered 22,72,831 shares. Qualified Institutional Buyers (QIB) are offered 45,45,662 shares in Religare Enterprises IPO and 15,00,000 shares in Saamya Biotech IPO.
| Religare Enterprises IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 45,45,662 shares | 15,00,000 shares |
| NII | 7,57,609 shares | 67,50,000 shares |
| RII | 22,72,831 shares | 67,50,000 shares |
| Employee | ||
| Others | ||
| Total | 75,76,102 shares | 1,50,00,000 shares |
Religare Enterprises IPO subscribed 160.56x in total, whereas Saamya Biotech IPO subscribed 16.61x.
| Religare Enterprises IPO | Saamya Biotech IPO | |
|---|---|---|
| QIB (times) | 184.95x | 10.99x |
| NII (times) | 215.45x | 7.36x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 93.50x | 27.12x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 160.56x | 16.61x |
